Quantcast
Last updated on April 24, 2014 at 5:50 EDT

Biogal Announces the Launch of the Canine VacciCheck in the USA

January 5, 2011

ORLANDO, Florida, January 5, 2011 /PRNewswire/ — Biogal-Galed Labs and
Modern Veterinary Therapeutics, LLC (Miami, FL) Announce the Official Launch
of Biogal’s Canine VacciCheck in the USA.

Biogal will officially launch the Canine VacciCheck in the USA at the
North American Veterinary Conference (NAVC) on January 15-19th 2011 in
Orlando, Florida. This conference is the major event of the year in the
United States
for the small animal veterinarian industry, attracting over
15,000 participants.

“We at Biogal see this as an ideal opportunity to present to our
customers a product that can assist in reducing over vaccination and
subsequent potential adverse reactions for dogs” said Amos Gershony, Biogal’s
General Manager.

The Canine VacciCheck kit is intended to be used as a diagnostic tool to
evaluate the antibody response to the core vaccination or infection by
Infectious Canine Hepatitis, Canine Parvovirus and Distemper Virus.

This test is especially useful to determine if a dog requires additional
vaccination, and may save the dog unnecessary vaccination. It is can also
help determine the vaccination status of a dog with unknown vaccination
history or help determine if puppies have received immunity from vaccination.

What is unique about Biogal’s ImmunoComb(R) Canine VacciCheck is that it
gives the veterinarian the opportunity of being able to quantitatively check
for all the 3 core vaccines. This is all done in one test as a follow up to
vaccination, in the vet’s clinic or the veterinary lab, with an answer
received within 20 minutes.

Please visit Biogal-Galed Labs at the North American Veterinary
Conference (NAVC) January 15-19th in Orlando, FL at booth number 3713 and /or
at the WVC in Las VegasFebruary 20-24th, booth number 576. To arrange a
booth tour, please contact Adie Lee at Adie@fetchingcommunications.com.

About Biogal-Galed Labs

Biogal – Galed Laboratories was founded in 1986 and developed the
ImmunoComb(R) technology, which is a quick, simple and portable Dot-ELISA
Test Kit, providing semi quantitative serological test results.

Biogal already has the following USDA approved products available in the
USA:

    - ImmunoComb(R) Feline Corona Virus (FCoV) [FIP] Antibody Test Kit
    - ImmunoComb(R) Murine ImmunoComb(R) Antibody Test Kit

To join Biogal-Galed Labs for up to the minute information, please visit
http://www.facebook.com/pages/Biogal/153070741406597,
http://www.twitter.com/biogal, or http://www.biogal.co.il

    Contact:

    Lenny Small, Marketing Manager
    Biogal Galed Labs
    Phone: +972-4-9898605
    e-mail: len@biogal.co.il

    In the USA:
    Modern Veterinary Therapeutics
    e-mail: info@modernveterinarytherapeutics.com

SOURCE Biogal-Galed Labs


Source: newswire